ArticleMolecular cancer therapeutics2022

The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.

Janik Puttemans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.